Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2020-03-15
Target enrollment:
Participant gender:
Summary
The efficacy of HIPEC in prevention of local recurrence, distant metastasis or peritoneal
metastasis in locally advanced colorectal cancer is not definite. The hypothesis of the trial
is that radical colorectal resection plus HIPEC is superior to only radical colorectal
resection in terms of overall survival.